vit D

ApprovedSmall molecule

PPost Graduate Institute of Medical Education and Research, Chandigarh

vit D is one of 314 small molecule programs targeting Vitamin D Deficiency. It is currently in Approved.

Indications

Total Trials

Active Trials

313

Competitors

Pipeline

Status by Indication[3][1]

Indication

Vitamin D DeficiencyActive, not recruiting

Thrombocytopenic PurpuraActive, not recruiting

Chronic HepatitisActive, not recruiting

UrticariaActive, not recruiting

AnemiaActive, not recruiting

Polycystic Ovary SyndromeActive, not recruiting

Breast CancerActive, not recruiting

Rheumatoid ArthritisActive, not recruiting

Alopecia AreataActive, not recruiting

COVID-19Active, not recruiting

Vitamin D DeficiencyPhase 1/Phase 2

Active, not recruiting

Thrombocytopenic PurpuraPhase 1

Active, not recruiting

Chronic HepatitisApproved

Active, not recruiting

UrticariaApproved

Active, not recruiting

AnemiaPhase 2/Phase 3

Active, not recruiting

Polycystic Ovary SyndromeApproved

Active, not recruiting

Breast CancerPreclinical

Active, not recruiting

Rheumatoid ArthritisPreclinical

Active, not recruiting

Alopecia AreataPreclinical

Active, not recruiting

COVID-19Preclinical

Active, not recruiting

Showing 10 of 13 indications

Competition

Competitive Landscape

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

vit D

PPost Graduate Institute of Medical Education and Research, Chandigarh

Approved

1 2

Lexiscan

Astellas

Preclinical

1 3

Blenoxane

Bristol-Myers Squibb

Preclinical

1 4

Zoladex

Luye Pharma Group Ltd.

Preclinical

8 5

Apatinib Mesylate

BBukwang Pharmaceutical

Preclinical

3 6

Motexafin Gadolinium

PPharmacyclics LLC.

Preclinical

1 7

Metfomin

UUniversity of Texas Southwestern Medical Center

Preclinical

1 8

Perflutren Lipid Microsphere

IImaRx Therapeutics

Preclinical

1 9

Iniparib

Sanofi

Preclinical

6 10

Tetracycline Hydrochloride

EEuropean Organisation for Research and Treatment of Cancer - EORTC

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2026

Phase 1/2Not yet recruiting

Vitamin D Deficiency

NCT06458686

Q4 2026

PreclinicalRecruiting

Dental Implant

NCT07684404

N/ARecruiting

Alopecia Areata

NCT06327581

Clinical

Trials by Indication[1]

Dental Implant2 trials

Systemic Vitamin D Supplementation in Dental Implants Patients

Completed·UUniversity Potiguar·Phase 4·NCT02582892·135 enrolled

Effect of Systemic Vitamin D on Dental Implant Osseointegration in Patients With Vitamin D Deficiency: A Randomized Controlled Clinical Study)

Recruiting·FFuture University in Egypt·Preclinical·NCT07684404·10 enrolled

Asthma2 trials

the Effect of Use of Vit d and Probiotic as a Supplementaition in the Treatment of Bronchial Asthma in Patient Aged 6 to 50 Year and Its Effect in Decrasing Excerbation.

Completed·—··NCT06962761·200 enrolled

Vitamin D Improves Clinical Manifestations in Asthmatic Children

Completed·TTanta University·Phase 1·NCT05167617·102 enrolled

Hypocalcemia1 trial

Vit D Role in Post Thyroidectomy Hypocalcemia

Unknown status·—·Phase 1·NCT04094493·30 enrolled

Thrombocytopenic Purpura1 trial

Use of Vitamin D as An Adjuvant Treatment in Children With Chronic Idiopathic Thrombocytopenic Purpura

Unknown status·MMansoura University·Phase 1·NCT06073925·30 enrolled

Overweight1 trial

Vitamin D3 Treatment and Homocysteine Concentrations Among Overweight Reproductive Women

Completed·—·Phase 2·NCT03310307·100 enrolled

11 more indications

Polycystic Ovary Syndrome1 trial

Vitamin D for Polycystic Ovary Syndrome Clomiphene Resistant Women

Completed·—·Phase 4·NCT04010942·120 enrolled

Vitamin D1 trial

Vitamin D and Hereditary Haemorrhagic Telangiectasia

Unknown status·SSt. Paul's Hospital, Canada·Phase 2·NCT03981562·60 enrolled

Chronic Hepatitis1 trial

Add Vitamin D With Standard of Care for Chronic Hepatitis C Patients

Completed·HHanyang University·Phase 4·NCT01439776·180 enrolled

Anemia1 trial

Different Treatment Modalities in the Management of the Painful Crisis in Pediatric Sickle- Cell Anemia

Completed·—·Phase 2/3·NCT04301336·350 enrolled

Urticaria1 trial

A Trial to Evaluate the Effect of Vitamin D Supplementation in Patients With Chronic Urticaria

Unknown status·PPost Graduate Institute of Medical Education and Research, Chandigarh·Phase 4·NCT03991845·262 enrolled

Alopecia Areata1 trial

Combined Microneedling With Either 1% Lactic Acid Solution or Vitamin D3 or Triamcinolone Acetonide in The Treatment of Alopecia Areata

Recruiting·ZZagazig University·N/A·NCT06327581·88 enrolled

Rheumatoid Arthritis1 trial

Vitamin d Level and it's Association With Disease Activity in Egyptian Rheumatoid Arthritis Patients

Unknown status·MMariam Samir Farg··NCT05486715·130 enrolled

MMR Vaccine1 trial

A Comparative Study to Assess Efficacy of Intralesional MMR Vaccine and Intralesional Vitamin D3 in Treatment of Warts

Completed·—·N/A·NCT04428359·66 enrolled

Breast Cancer1 trial

Vitamin D Can Increase Pathological Response of the Breast Cancer Patients Treated With Neoadjuvant Therapy

Completed·—·N/A·NCT03986268·64 enrolled

Vitamin D Deficiency1 trial

Effect of Vitamin D Supplementation on Mental Health: An Exploratory Study on A University Students Suffering From Vitamin D Deficiency

Not yet recruiting·GGerman University in Cairo·Phase 1/2·NCT06458686·70 enrolled

COVID-191 trial

Short Term, High Dose Vitamin D Supplementation for COVID-19

Completed·PPost Graduate Institute of Medical Education and Research, Chandigarh·N/A·NCT04459247·40 enrolled

Sources

References

[1]
ClinicalTrials.gov — 18 trial records for vit D. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — vit D compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for vit D. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Post Graduate Institute of Medical Education and Research, Chandigarh company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Approved[1]
Company: PPost Graduate Institute of Medical Education and Research, Chandigarh

vit D

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2026

Q4 2026

Trials by Indication[1]

Dental Implant2 trials

Asthma2 trials

Hypocalcemia1 trial

Thrombocytopenic Purpura1 trial

Overweight1 trial

Polycystic Ovary Syndrome1 trial

Vitamin D1 trial

Chronic Hepatitis1 trial

Anemia1 trial

Urticaria1 trial

Alopecia Areata1 trial

Rheumatoid Arthritis1 trial

MMR Vaccine1 trial

Breast Cancer1 trial

Vitamin D Deficiency1 trial

COVID-191 trial

References

Drug Info

Quick Facts

Related News